322 related articles for article (PubMed ID: 30560540)
1. Hepatitis C virus infection and chronic renal disease: A review.
Goel A; Bhadauria DS; Aggarwal R
Indian J Gastroenterol; 2018 Nov; 37(6):492-503. PubMed ID: 30560540
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL;
Dig Liver Dis; 2018 Nov; 50(11):1133-1152. PubMed ID: 30266305
[TBL] [Abstract][Full Text] [Related]
3. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
4. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.
Jadoul M; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Gordon CE; Earley A; Di M; Martin P
Kidney Int; 2018 Oct; 94(4):663-673. PubMed ID: 30243313
[TBL] [Abstract][Full Text] [Related]
5. [Direct-acting antiviral agents, hepatitis C and dialysis: an update].
Fabrizi F; Lampertico P; Messa P
G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234230
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
Intern Emerg Med; 2018 Dec; 13(8):1139-1166. PubMed ID: 30255464
[TBL] [Abstract][Full Text] [Related]
7. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
J Nephrol; 2018 Oct; 31(5):685-712. PubMed ID: 30255440
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis C infection among patients with renal failure.
Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
[TBL] [Abstract][Full Text] [Related]
9. Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease.
Gordon CE; Balk EM; Francis JM
Semin Dial; 2019 Mar; 32(2):187-195. PubMed ID: 30496617
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis C virus and chronic progressive kidney disease].
Kes P; Slavicek J
Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline.
Awan AA; Jadoul M; Martin P
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2158-2167. PubMed ID: 31376491
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis c virus and chronic kidney disease.
Khan MU; Mahmoud MI; Butt AA
Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):579-590. PubMed ID: 32613874
[TBL] [Abstract][Full Text] [Related]
13. What are the management issues for hepatitis C in dialysis patients?: epidemiology and prevention of hepatitis C virus transmission in the hemodialysis setting.
Jadoul M; Fabrizi F
Semin Dial; 2014; 27(5):449-51. PubMed ID: 25204877
[No Abstract] [Full Text] [Related]
14. Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens.
Puenpatom A; Hull M; McPheeters J; Schwebke K
Clin Drug Investig; 2017 Jul; 37(7):687-697. PubMed ID: 28386819
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
Kim SM; Song IH
Korean J Intern Med; 2018 Jul; 33(4):670-678. PubMed ID: 29961309
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective.
Jadoul M; Martin P
Blood Purif; 2017; 43(1-3):206-209. PubMed ID: 28114144
[TBL] [Abstract][Full Text] [Related]
17. Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease.
Manoj Kumar ; Nayak SL; Gupta E; Kataria A; Sarin SK
Liver Int; 2018 Dec; 38(12):2137-2148. PubMed ID: 29676846
[TBL] [Abstract][Full Text] [Related]
18. Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis.
Fabrizi F; Donato FM; Messa P
Int J Artif Organs; 2017 Oct; 40(10):531-541. PubMed ID: 28708211
[TBL] [Abstract][Full Text] [Related]
19. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
20. Management of hepatitis C in patients with chronic kidney disease.
Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
